4 Comments

Green says "lack of other alternatives". What he or she means is lack of other pharmaceutical companies paying us to look at their drugs, so we might as well approve this one. Thanks for the chicken scratch notes. 🐤🐤🐤🐤🐤🐤

Expand full comment

Yes, it was honestly strange that they were trying to criticize the MAbs, even though they have worked extremely well so far. As for other drugs that shall not be named, I find all of this ridiculous considering that Molnupiravir has a marginal efficacy profile yet a high/uncertain toxicity profile, especially one that can cause long lasting reproductive harm which may be passed onto offspring. Apparently all of that makes this drug acceptable but don't you dare look at those other drugs which honestly seem to have a much longer safety history.

Expand full comment

I love it, other drugs that "shall not be named". 😄 I truly wonder if they access studies about "those other drugs" with proven safety profiles and dosages. I imagine they're under the same corporate government information influence that the rest of the population is. They're just people after all, and they may think that it's the anti-vaxxers or Trump loving maga's that are pushing those drugs, and thus they're not even worth considering.

Expand full comment

That type of heuristic thinking that has pervaded the COVID arena has been one of the most damning things to come about honestly. I legitimately cannot believe how being critical of the COVID narrative in any manner pushes people to the right. I think the bright side is that many people are waking up to this and starting to notice the inconsistencies that are being pushed. I do hope more people begin to call this stuff out even further especially with these massive push for boosters.

Expand full comment